Relapsed or Refractory Anaplastic Large-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Anaplastic Large-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma (NCT01492088) | Millennium Pharmaceuticals, Inc. | 2012-04-16 |
Track Relapsed or Refractory Anaplastic Large-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.